ADPT
$24.42+1.96%
Adaptive Biotechnologies CorporationStock · HealthcareRussell 2000 · 0.1% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.005% of IWVUS Stock Market · 0.005% of VTI
ADPT — Adaptive Biotechnologies Corporation price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEE
10.020.030.040.050.060.0010.0M20.0M$24.42—20192021202320242026
2026-10-20
Price$24.42
MA20$24.92
MA50$19.41
Vol4.4M
Key stats#
Price data
- Price
- $24.42
- YTD price return
- +50.37%
- YTD total return
- +50.37%
- Next earnings
- Nov 4, 2026 · After close
- Market cap
- 3.9B
- Enterprise value
- 3.8B
- Shares outstanding
- 159.6M
- 52W low
- $12.00
- 52W high
- $30.74
- From 52W high
- -20.56%
- From 52W low
- +103.50%
- 52W range
- 66%
Volume
- Rel volume
- 0.53×
- 30D volume
- 2.3M
- 30D $ vol
- 63.2M
Fundamentals
- Sales (ttm)
- 308.1M
- Sales/share
- $1.93
- EPS (ttm)
- -$0.40
- FCF (ttm)
- -24M
- FCF/share
- -$0.15
- Book value/share
- $0.90
- Net margin
- -20.73%
- ROE
- -44.68%
- ROA
- -9.97%
- Debt / equity
- 0.00×
- Current ratio
- 4.79
Growth (CAGR, ttm) · 10Y
- Sales
- +50.17%+17.56%+18.22%n/a
- Shares
- +4.81%+3.33%+2.54%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +43.27%+13.77%+15.29%n/a
- Book value/share
- -24.14%-31.10%-28.89%n/a
- Price
- +36.99%+80.95%-6.37%n/a
- Total return
- +36.99%+80.95%-6.37%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -60.4×
- Fwd P/E
- -133.2×
- P/S (ttm)
- 12.7×
- P/B (mrq)
- 27.3×
- EV/Sales (ttm)
- 12.4×
- FCF yield (ttm)
- -0.62%
- Buyback yield (realized, 1y)
- -4.81%
- Shareholder yield (realized, 1y)
- -4.81%
- Buyback yield (cash, ttm)
- 0.64%
- Shareholder yield (cash, ttm)
- 0.64%
Vs own 10Y history
- P/S
- 61st
- P/B
- 97th
Bar = where today’s multiple sits in ADPT’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.96%
5D
-3.40%
1M
-14.65%
3M
+11.71%
YTD
+50.37%
1Y
+36.96%
5Y
-28.03%
Financial statements
Open full ADPT financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
